147 related articles for article (PubMed ID: 8474239)
1. Influence of the timing of blood transfusion on experimental tumor growth.
Francis DM; Clunie GJ
J Surg Res; 1993 Mar; 54(3):237-41. PubMed ID: 8474239
[TBL] [Abstract][Full Text] [Related]
2. Soluble and cell-associated forms of some yet to be identified factor in transfused blood which promotes solid tumor growth in mice.
Okuyama M; Motoyama S; Saito S; Saito R; Nakamura M; Imano H; Minamiya Y; Ogawa J
Surg Today; 2004; 34(8):673-7. PubMed ID: 15290397
[TBL] [Abstract][Full Text] [Related]
3. Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen.
Clark DA; Gorczynski RM; Blajchman MA
Transfusion; 2008 May; 48(5):814-21. PubMed ID: 18298594
[TBL] [Abstract][Full Text] [Related]
4. Acceleration of B16 melanoma growth in mice after blood transfusion.
Francis DM; Burren CP; Clunie GJ
Surgery; 1987 Sep; 102(3):485-92. PubMed ID: 3629476
[TBL] [Abstract][Full Text] [Related]
5. Effects of hypovolemia and transfusion on tumor growth in MCA-tumor-bearing rats.
Younes RN; Rogatko A; Vydelingum NA; Brennan MF
Surgery; 1991 Mar; 109(3 Pt 1):307-12. PubMed ID: 2000562
[TBL] [Abstract][Full Text] [Related]
6. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
Da Costa ML; Redmond HP; Bouchier-Hayes DJ
J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264
[TBL] [Abstract][Full Text] [Related]
7. Early vaccination with tumor-lysate-pulsed dendritic cells after allogeneic bone marrow transplantation has antitumor effects.
Moyer JS; Maine G; Mulé JJ
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1010-9. PubMed ID: 17084367
[TBL] [Abstract][Full Text] [Related]
8. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
[TBL] [Abstract][Full Text] [Related]
9. Blood transfusion and surgery: the effect on growth of a syngeneic sarcoma.
Parrott NR; Lennard TW; Proud G; Shenton BK; Givan A; White MD; Taylor R
Ann R Coll Surg Engl; 1990 Mar; 72(2):77-81. PubMed ID: 2334101
[TBL] [Abstract][Full Text] [Related]
10. Is immunosuppression at the tumor site mechanism of evasion of a systemic response?
Karakousis CP; Sharma S; Brooks SP
J Med; 2003; 34(1-6):3-14. PubMed ID: 17682306
[TBL] [Abstract][Full Text] [Related]
11. [Effects of hyperbaric oxygenation on tumor growth].
Frid IA; Sapov IA; Katyshev AV; Lupanov AI; Rudakov VF; Semiachkina SO; Shul'ga NI
Vopr Onkol; 1989; 35(8):970-3. PubMed ID: 2800446
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic cell therapy for a murine mammary carcinoma.
Morecki S; Yacovlev E; Diab A; Slavin S
Cancer Res; 1998 Sep; 58(17):3891-5. PubMed ID: 9731499
[TBL] [Abstract][Full Text] [Related]
13. Influence of quercetin on B16 melanotic melanoma growth in C57BL/6 mice and on activity of some acid hydrolases in melanoma tissue.
Drewa G; Woźqak A; Pałgan K; Schachtschabel DO; Grzanka A; Sujkowska R
Neoplasma; 2001; 48(1):12-8. PubMed ID: 11327532
[TBL] [Abstract][Full Text] [Related]
14. [Effect of histamine on metastasis of melanoma B16 cell xenograft in C57BL/6 mice].
Qin YS; Zhang X; Li L; Yu HL
Ai Zheng; 2007 Aug; 26(8):833-6. PubMed ID: 17697542
[TBL] [Abstract][Full Text] [Related]
15. [Anti-tumor effect through human endostatin gene transfer in mice bearing B16 melanoma].
Zhang B; Zou W; Wu G; Jin D; Xu D; Zheng Z; Wu Z; Liu X
Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):451-4. PubMed ID: 12485496
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
17. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
Yoshida R; Yoneda Y; Kuriyama M; Kubota T
J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
[TBL] [Abstract][Full Text] [Related]
18. [Effect of immunomodulation following allogeneic blood transfusion on tumor neogenesis and growth--experimental studies in rats].
Scholler PM; Zeller WJ; Rössler W; Lenhard V; Weber E; Schmähl D; Dreikorn K
Arch Geschwulstforsch; 1987; 57(2):81-90. PubMed ID: 3592925
[TBL] [Abstract][Full Text] [Related]
19. Adoptive transfer of immature dendritic cells with autologous or allogeneic tumor cells generates systemic antitumor immunity.
Melcher A; Todryk S; Bateman A; Chong H; Lemoine NR; Vile RG
Cancer Res; 1999 Jun; 59(12):2802-5. PubMed ID: 10383135
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells.
Hyoudou K; Nishikawa M; Umeyama Y; Kobayashi Y; Yamashita F; Hashida M
Clin Cancer Res; 2004 Nov; 10(22):7685-91. PubMed ID: 15570002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
